Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
Nekesha Oliphant MD
Nekesha Oliphant MD Advisory Board
See All Experts
featured
Published in Primary Care

Journal Scan / Research · May 14, 2020

Use of SGLT2 Inhibitors and Risk of Serious Renal Events

BMJ: British Medical Journal

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

BMJ: British Medical Journal
Use of Sodium-Glucose Co-Transporter 2 Inhibitors and Risk of Serious Renal Events: Scandinavian Cohort Study
BMJ 2020 Apr 29;369(xx)m1186, B Pasternak, V Wintzell, M Melbye, B Eliasson, AM Svensson, S Franzén, S Gudbjörnsdottir, K Hveem, C Jonasson, H Svanström, P Ueda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated